Figure 1.
Psoriasis lesions of the upper and lower limbs at baseline (T0) and after 4 (T4) and 10 months (T10) of treatment with semaglutide in addition to metformin. PASI, psoriasis area and severity index; DLQI, dermatology life quality index.
Psoriasis lesions of the upper and lower limbs at baseline (T0) and after 4 (T4) and 10 months (T10) of treatment with semaglutide in addition to metformin. PASI, psoriasis area and severity index; DLQI, dermatology life quality index.